About Us

Dr. Brennan has 20 years of medical device and regenerative medicine experience. She previously managed a $165M global breast reconstruction and aesthetics business at Establishment Labs. She also previously developed and led the strategic direction of MTF Biologics’ Plastic and Reconstructive Surgery Franchise, growing revenue by 500% and solidifying a leadership spot for the company in post-mastectomy breast reconstruction. Dr. Brennan received her Ph.D. in biomedical engineering from Rutgers University and her bachelor’s degree in mechanical engineering from Lehigh University.

Dr. Blum is an expert in residence for NCBiotech and has spent over 20 years combining her scientific technical expertise with bioengineered regenerative tissue development. As a co-founder and former Executive Vice President of Corporate Development of Humacyte, a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at a commercial scale. She received her doctorate in Molecular Biology from Loyola University Chicago with a focus in cardiovascular gene therapy and her bachelors’ degree at Carthage College in Wisconsin.

Previously serving as President and Principal Executive Officer at Furiex (Acquired by Actavis for $1.2B), COO and CMO of Innovate Biopharmaceuticals, and with 13 years in GSK’s R&D, June brings significant experience guiding technologies from pre-clinic to product, including development of regulatory and commercial strategy.

Diane Gomez-Thinnes is a two-time President, having served as U.S. President, Galderma and as Worldwide President, Mentor, a Johnson & Johnson company. Diane is a results-focused, commercial strategy expert with proven success in the medtech, consumer care, and pharmaceutical sectors.  Her career spans two decades paving pathways for disruptive innovation and novel commercialization efforts in the industry across various specialty areas: dermatology, plastic & reconstructive surgery, biosurgery, interventional cardiology, neurovascular, and peripheral vascular.

Dr. Canady is the former President of the American Society of Plastic Surgery, with more than 30 years of experience in practice. He also served as Head of the Medical Affairs group in Cardiovascular and Specialty Solutions Group, a Johnson & Johnson Company that included Biosense Webster, Advanced Sterilization Products, Mentor, Acclarent, Sterilmed and Sedasys.

Anne is a dual-trained plastic and breast surgeon. After  graduating Harvard Medical School, she completed a plastic and reconstructive surgery residency and a breast surgical oncology fellowship at the University of California, San Francisco.  Just a few years into starting her own thriving breast cancer and plastic surgery practice, Anne was diagnosed with breast cancer herself, which gives her the unusual perspective of both the expert and the patient.

Dr. Sara Dickie has been practicing plastic surgery in the Chicago area for over 10 years. She is certified by the American Board of Plastic Surgery and holds leadership roles in national and regional plastic surgery societies. Dr. Dickie’s practice is highly collaborative, working closely with professionals in Dermatology, Aesthetic Medicine, MOHS Surgery, and Plastic Surgery. With expertise in Plastic & Reconstructive Surgery, Global Medicine, Soft Tissue Surgery, Medical Education, and Patient Safety, she is passionate about helping patients look and feel their best, respecting each individual’s unique goals.

Dr. David Turer is a board-certified plastic surgeon and biomedical engineer with a private practice in Pittsburgh, PA, and an academic role as an Assistant Professor of Plastic Surgery at the University of Pittsburgh. His combined expertise in surgery and engineering brings a unique perspective to medical technology. Dr. Turer is deeply involved in developing innovative medical devices, driven by his passion for blending art and science to achieve exceptional patient outcomes.

Larry is a results-driven MBA and CPA with 20+ years of CFO, Controllership, and Treasury leadership experience with entrepreneurial, high growth, and transitioning healthcare and technology companies. Larry has a track record of being a catalyst for change, innovation, and growth backed by a solid history of transforming robust business goals into strategies for unlocking value and driving strong top and bottom-line results.

Ms. Charles brings 20 years’ experience steering medical devices through agency oversight to market, and deep expertise in the reconstruction and augmentation regulatory environment. Prior to inSoma, she served as Senior Director of Global Regulatory Affairs at Establishment Labs. Across her career, she has successfully navigated the regulatory landscape for products including donor organ preservation systems, cancer screening products, and coagulopathy testing. She received her  Master’s in developmental psychobiology from Indiana University–Bloomington and a B.S. in psychology from Brown University.

Matthew received his B.S. from the University of Miami and M.S. from University of South Florida, obtaining a degree in Biology/Microbiology. For the past 20 years he has worked in natural products discovery from bacteria, specializing in microbial growth/isolation and fermentation, as well as downstream purification processes for proteins and polysaccharides.

Emily received her B.S and M.S in Biomedical Engineering from Case Western Reserve University. Prior to inSoma, her work focused on the implementation of an injectable implant for the localized treatment of liver and prostate cancer. Her role in those projects was focused on the design, implementation, and analysis of animal treatment models.

Dr. Nelson earned his Ph.D. in biomedical engineering from Rensselaer Polytechnic Institute and his B.S. in chemical and biological engineering from the University of New Mexico. His doctoral research focused on biomaterials for neural engineering, encompassing the fields of recombinant technology, drug delivery, and genetic engineering. He also has research and clinical experience from a national lab, a biotech startup, and an engineering incubator, resulting in multiple publications and patents.

Dr. Olney received his B.S and Ph.D. from Indiana University-Bloomington, obtaining both degrees in Microbiology with a focus on bacteriology, genetics and biochemistry. Prior to inSoma, Stephen’s work focused on how bacteria sense their environments and the biomolecular changes that occur to affect bacterial physiology and behavior.

Erin received her B.S. in Biology from Salem College with minors in Chemistry and Mathematics. Prior to inSoma, her research focused on plant-microbe interactions as well as nucleic acid extraction. She has a developing interest in microbiology and its use in biomedical engineering.